Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 6Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Diarrhea 3Colitis 3Urogenital Neoplasms 2Solid Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Mesothelioma 1Lymphoma, Non-Hodgkin 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Fecal Microbiota Transplantation × Clear all
NCT06405113 2025-02-20

FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer

Changzhou No.2 People's Hospital

Phase 2 Recruiting
198 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡